High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma

被引：0
|
作者：
Vigouroux, Stephane [1 ]
Gaillard, Fanny [2 ]
Moreau, Philippe [1 ]
Harousseau, Jean-Luc [1 ]
Milpied, Noel [1 ]
机构：
[1] CHU Hotel Dieu, Serv Hematol Clin, 1 Pl Alexis Ricordeau, F-44000 Nantes, France
[2] CHU Hotel Dieu, Lab Anat Pathol, Nantes, France
来源：
HAEMATOLOGICA | 2005年 / 90卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We retrospectively investigated the outcome of 30 newly diagnosed patients with mantle cell lymphoma treated with high-dose therapy and autologous stem cell transplantation in first response. With a median follow-up of 55 months, the 5-year overall-survival is 62%, the 5-year progression-free-survival is 40% and no secondary malignancy has occurred.
引用
收藏
页码：1580 / 1582
页数：3
相关论文
共 50 条
  • [21] Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation
    Bernd Metzner
    Thomas H. Müller
    Wolfgang Gebauer
    Jochen Casper
    Doris Kraemer
    Bernd Rosien
    Silke Schumann-Binarsch
    Ruth Thole
    Claus H. Köhne
    Martin Dreyling
    Eva Hoster
    Christiane Pott
    Annals of Hematology, 2014, 93 : 803 - 810
  • [22] High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma - The seattle experience
    Gopal, Ajay K.
    Metcalfe, Tracee L.
    Gooley, Ted A.
    Pagel, John M.
    Petersdorf, Stephen H.
    Bensinger, William I.
    Holmberg, Leona
    Maloney, David G.
    Press, Oliver W.
    CANCER, 2008, 113 (06) : 1344 - 1350
  • [23] HIGH-DOSE THERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED FOLLICULAR LYMPHOMA: THE ARGENTINEAN EXPERIENCE
    Garcia, P.
    De Goycoechea, D.
    Berro, M.
    Tabar, J.
    Yantorno, S.
    Nappal, J.
    Rivas, M.
    Prates, M.
    Molnar, S.
    Rizzi, M.
    Basquiera, A.
    Jarchum, G.
    Milone, J.
    Kusminsky, G.
    Garcia, J.
    HAEMATOLOGICA, 2012, 97 : 660 - 660
  • [24] Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma
    T Y Kang
    L A Rybicki
    B J Bolwell
    S G Thakkar
    S Brown
    R Dean
    M A Sekeres
    A Advani
    R Sobecks
    M Kalaycio
    B Pohlman
    J W Sweetenham
    Bone Marrow Transplantation, 2007, 40 : 973 - 978
  • [25] High dose therapy with autologous stem cell transplantation as first line therapy in mantle cell lymphoma: A monocentric experience with extended follow-up
    Vigouroux, S
    Gaillard, F
    Harousseau, J
    Milpied, N
    ANNALS OF ONCOLOGY, 2005, 16 : 170 - 170
  • [26] High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma
    Gopal, AK
    Rajendran, JG
    Petersdorf, SH
    Maloney, DG
    Eary, JF
    Wood, BL
    Gooley, TA
    Bush, SA
    Durack, LD
    Martin, PJ
    Matthews, DC
    Appelbaum, FR
    Bernstein, ID
    Press, OW
    BLOOD, 2002, 99 (09) : 3158 - 3162
  • [27] High-dose therapy with stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience
    N Milpied
    F Gaillard
    P Moreau
    B Mahé
    J Souchet
    MJ Rapp
    CE Bulabois
    N Morineau
    JL Harousseau
    Bone Marrow Transplantation, 1998, 22 : 645 - 650
  • [28] Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving High-Dose Therapy and Autologous Stem-Cell Transplantation
    Budde, Lihua E.
    Guthrie, Katherine A.
    Till, Brian G.
    Press, Oliver W.
    Chauncey, Thomas R.
    Pagel, John M.
    Petersdorf, Steven H.
    Bensinger, William I.
    Holmberg, Leona A.
    Shustov, Andrei R.
    Green, Damian J.
    Maloney, David G.
    Gopal, Ajay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) : 3023 - 3029
  • [29] High-dose therapy with stem cell transplantation for mantle cell lymphoma:: results and prognostic factors, a single center experience
    Milpied, N
    Gaillard, F
    Moreau, P
    Mahé, B
    Souchet, J
    Rapp, MJ
    Bulabois, CE
    Morineau, N
    Harousseau, JL
    BONE MARROW TRANSPLANTATION, 1998, 22 (07) : 645 - 650
  • [30] High-dose therapy with purged autologous stem cell transplantation (ASCT) as firstline therapy for follicular lymphoma.
    Wattad, M
    Lange, E
    Erbers, S
    Balleisen, L
    Heit, W
    BLOOD, 2000, 96 (11) : 376B - 376B
12345